Airspace miR-146a levels in ventilated patients decrease with age and correlate with mortality
Preprint
Abstract
The acute respiratory distress syndrome is a heterogenous syndrome characterized by the rapid development of respiratory failure. Nearly 40% of patients who develop ARDS will die, and there is growing interest in identification of biomarkers to identify patients at risk of death and/or inform treatment decisions. Most prior work on biomarkers in ARDS has focused on the plasma compartment, but there is concern that circulating biomarkers may not reflect alveolar pathobiology. The anti-inflammatory microRNA-146a has been shown to be upregulated in inflammatory cells in human bronchoalveolar lavage fluid, but it is not known if these levels correspond with outcomes. We measured miR-146a expression by digital droplet PCR in human biospecimens from four different cohorts of patients with respiratory failure requiring mechanical ventilation – two plasma cohorts, one bronchoalveolar lavage cohort, and one heat moisture exchange (HME) filter fluid cohort. We found that miR-146a was detectible in plasma, bronchoalveolar lavage fluid, and HME fluid. However, only when measured in the alveolar space, was miR-146a expression significantly lower in older adults and those who died. It did not correlate with outcomes when measured in plasma. To our knowledge, this is the first report that nucleotides can be measured in HME fluid and builds upon expanding literature that circulating biomarkers may not reflect complex biology of the alveolar microenvironment during ARDS.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (F32 HL176082)
- National Heart, Lung, and Blood Institute (T32 HL166132)
- National Heart, Lung, and Blood Institute (R01 HL169265)
- National Heart, Lung, and Blood Institute (K08 HL169725)
- National Heart, Lung, and Blood Institute (R01 HL149676)
- National Heart, Lung, and Blood Institute (R01 HL160551)
This publication has 10 references indexed in Scilit:
- Plasma proteomic profiles correlate with organ dysfunction in COVID‐19 ARDSPhysiological Reports, 2025
- A New Global Definition of Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2024
- Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDSJCI Insight, 2021
- Nanoparticle delivery of microRNA-146a regulates mechanotransduction in lung macrophages and mitigates injury during mechanical ventilationNature Communications, 2021
- Increased mortality in elderly patients with acute respiratory distress syndrome is not explained by host responseIntensive Care Medicine Experimental, 2019
- Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trialThe Lancet Respiratory Medicine, 2018
- Cytometry TOF identifies alveolar macrophage subtypes in acute respiratory distress syndromeJCI Insight, 2018
- Novel Method for Noninvasive Sampling of the Distal Airspace in Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 CountriesJAMA, 2016
- Randomized, Placebo-controlled Clinical Trial of an Aerosolized β2-Agonist for Treatment of Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2011